Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.

Marino Y, Rottura M, Ligresti C, Battaglia A, De Francesco C, Irrera N, Arcoraci V, Fries W, Viola A, Pallio G

Open source

DOI
10.3390/ph19091428
Published
2026 Sep 10
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091428,
  title = {Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.},
  author = {Marino Y and Rottura M and Ligresti C and Battaglia A and De Francesco C and Irrera N and Arcoraci V and Fries W and Viola A and Pallio G},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091428},
  url = {https://doi.org/10.3390/ph19091428}
}

RIS

TY  - JOUR
TI  - Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.
AU  - Marino Y
AU  - Rottura M
AU  - Ligresti C
AU  - Battaglia A
AU  - De Francesco C
AU  - Irrera N
AU  - Arcoraci V
AU  - Fries W
AU  - Viola A
AU  - Pallio G
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091428
UR  - https://doi.org/10.3390/ph19091428
ER  - 

APA

Y, M., M, R., C, L., A, B., C, D. F., N, I., V, A., W, F., A, V., & G, P. (2026). Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091428

Source records